Literature DB >> 23674786

Improved subthalamic nucleus depiction with quantitative susceptibility mapping.

Tian Liu1, Sarah Eskreis-Winkler, Andrew D Schweitzer, Weiwei Chen, Michael G Kaplitt, A John Tsiouris, Yi Wang.   

Abstract

PURPOSE: To assess quantitative susceptibility mapping (QSM) in the depiction of the subthalamic nucleus (STN) by using 3-T magnetic resonance (MR) imaging.
MATERIALS AND METHODS: This study was HIPAA compliant and institutional review board approved. Ten healthy subjects (five men, five women; mean age, 24 years ± 3 [standard deviation]; age range, 21-33 years) and eight patients with Parkinson disease (five men, three women; mean age, 57 years ± 14; age range, 25-69 years) who were referred by neurologists for preoperative navigation MR imaging prior to deep brain stimulator placement were included in this study. T2-weighted (T2w), T2*-weighted (T2*w), R2* mapping (R2*), phase, susceptibility-weighted (SW), and QSM images were reconstructed for STN depiction. Qualitative visualization scores of STN and internal globus pallidus (GPi) were recorded by two neuroradiologists on all images. Contrast-to-noise ratios (CNRs) of the STN and GPi were also measured. Measurement differences were assessed by using the Wilcoxon rank sum test and the signed rank test.
RESULTS: Qualitative scores were significantly higher on QSM images than on T2w, T2*w, R2*, phase, or SW images (P < .05) for STN and GPi visualization. Median CNR was 6.4 and 10.7 times higher on QSM images than on T2w images for differentiation of STN from the zona incerta and substantia nigra, respectively, and was 22.7 and 9.1 times higher on QSM images than on T2w images for differentiation of GPi from the internal capsule and external globus pallidus, respectively. CNR differences between QSM images and all other images were significant (P < .01).
CONCLUSION: QSM at 3-T MR imaging performs significantly better than current standard-of-care sequences in the depiction of the STN. © RSNA, 2013.

Entities:  

Mesh:

Year:  2013        PMID: 23674786      PMCID: PMC3781358          DOI: 10.1148/radiol.13121991

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  30 in total

1.  Artery and vein separation using susceptibility-dependent phase in contrast-enhanced MRA.

Authors:  Y Wang; Y Yu; D Li; K T Bae; J J Brown; W Lin; E M Haacke
Journal:  J Magn Reson Imaging       Date:  2000-11       Impact factor: 4.813

2.  Electric field and stimulating influence generated by deep brain stimulation of the subthalamic nucleus.

Authors:  Cameron C McIntyre; Susumu Mori; David L Sherman; Nitish V Thakor; Jerrold L Vitek
Journal:  Clin Neurophysiol       Date:  2004-03       Impact factor: 3.708

Review 3.  Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson's disease and tremor.

Authors:  Robert E Gross; Paul Krack; Maria C Rodriguez-Oroz; Ali R Rezai; Alim-Louis Benabid
Journal:  Mov Disord       Date:  2006-06       Impact factor: 10.338

4.  Deep brain stimulation: preoperative issues.

Authors:  Anthony E Lang; Jean-Luc Houeto; Paul Krack; Cynthia Kubu; Kelly E Lyons; Elena Moro; William Ondo; Rajesh Pahwa; Werner Poewe; Alexander I Tröster; Ryan Uitti; Valerie Voon
Journal:  Mov Disord       Date:  2006-06       Impact factor: 10.338

5.  Pretargeting for the implantation of stimulation electrodes into the subthalamic nucleus: a comparative study of magnetic resonance imaging and ventriculography.

Authors:  Sorin Breit; Jean-Francois LeBas; Adnan Koudsie; Jörg Schulz; Abdelhamid Benazzouz; Pierre Pollak; Alim-Louis Benabid
Journal:  Neurosurgery       Date:  2006-02       Impact factor: 4.654

6.  Study of movement disorders and brain iron by MR.

Authors:  J N Rutledge; S K Hilal; A J Silver; R Defendini; S Fahn
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

7.  Side-effects of subthalamic stimulation in Parkinson's disease: clinical evolution and predictive factors.

Authors:  D Guehl; E Cuny; A Benazzouz; A Rougier; F Tison; S Machado; D Grabot; C Gross; B Bioulac; P Burbaud
Journal:  Eur J Neurol       Date:  2006-09       Impact factor: 6.089

8.  Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data.

Authors:  Didier Dormont; Kenneth G Ricciardi; Dominique Tandé; Karine Parain; Carole Menuel; Damien Galanaud; Soledad Navarro; Philippe Cornu; Yves Agid; Jérôme Yelnik
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

9.  Tissue characterization with T1, T2, and proton density values: results in 160 patients with brain tumors.

Authors:  M Just; M Thelen
Journal:  Radiology       Date:  1988-12       Impact factor: 11.105

10.  Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Authors:  P Limousin; P Krack; P Pollak; A Benazzouz; C Ardouin; D Hoffmann; A L Benabid
Journal:  N Engl J Med       Date:  1998-10-15       Impact factor: 91.245

View more
  48 in total

1.  Internal structures of the globus pallidus in patients with Parkinson's disease: evaluation with quantitative susceptibility mapping (QSM).

Authors:  Satoru Ide; Shingo Kakeda; Issei Ueda; Keita Watanabe; Yu Murakami; Junji Moriya; Atsushi Ogasawara; Koichiro Futatsuya; Toru Sato; Norihiro Ohnari; Kazumasa Okada; Atsuji Matsuyama; Hitoshi Fujiwara; Masanori Hisaoka; Sadatoshi Tsuji; Tian Liu; Yi Wang; Yukunori Korogi
Journal:  Eur Radiol       Date:  2014-11-01       Impact factor: 5.315

2.  Rapid multi-orientation quantitative susceptibility mapping.

Authors:  Berkin Bilgic; Luke Xie; Russell Dibb; Christian Langkammer; Aysegul Mutluay; Huihui Ye; Jonathan R Polimeni; Jean Augustinack; Chunlei Liu; Lawrence L Wald; Kawin Setsompop
Journal:  Neuroimage       Date:  2015-08-12       Impact factor: 6.556

3.  Quantitative Analysis of Punctate White Matter Lesions in Neonates Using Quantitative Susceptibility Mapping and R2* Relaxation.

Authors:  Y Zhang; A Rauscher; C Kames; A M Weber
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-20       Impact factor: 3.825

4.  Automated adaptive preconditioner for quantitative susceptibility mapping.

Authors:  Zhe Liu; Yan Wen; Pascal Spincemaille; Shun Zhang; Yihao Yao; Thanh D Nguyen; Yi Wang
Journal:  Magn Reson Med       Date:  2019-08-11       Impact factor: 4.668

Review 5.  Introduction to Quantitative Susceptibility Mapping and Susceptibility Weighted Imaging.

Authors:  Pascal P R Ruetten; Jonathan H Gillard; Martin J Graves
Journal:  Br J Radiol       Date:  2019-07-26       Impact factor: 3.039

6.  Direct visualization of deep brain stimulation targets in patients with Parkinson's disease via 3-T quantitative susceptibility mapping.

Authors:  Kaijia Yu; Zhiwei Ren; Jianyu Li; Song Guo; Yongsheng Hu; Yongjie Li
Journal:  Acta Neurochir (Wien)       Date:  2021-02-11       Impact factor: 2.216

7.  Rapid automated liver quantitative susceptibility mapping.

Authors:  Ramin Jafari; Sujit Sheth; Pascal Spincemaille; Thanh D Nguyen; Martin R Prince; Yan Wen; Yihao Guo; Kofi Deh; Zhe Liu; Daniel Margolis; Gary M Brittenham; Andrea S Kierans; Yi Wang
Journal:  J Magn Reson Imaging       Date:  2019-01-13       Impact factor: 4.813

8.  Quantitative Susceptibility Mapping Is Superior to T1-weighted Imaging for Detecting and Measuring Gadolinium.

Authors:  Yi Wang; Martin R Prince
Journal:  Radiology       Date:  2020-07-21       Impact factor: 11.105

9.  Clinical Integration of Automated Processing for Brain Quantitative Susceptibility Mapping: Multi-Site Reproducibility and Single-Site Robustness.

Authors:  Pascal Spincemaille; Zhe Liu; Shun Zhang; Ilhami Kovanlikaya; Matteo Ippoliti; Marcus Makowski; Richard Watts; Ludovic de Rochefort; Vijay Venkatraman; Patricia Desmond; Mathieu D Santin; Stéphane Lehéricy; Brian H Kopell; Patrice Péran; Yi Wang
Journal:  J Neuroimaging       Date:  2019-08-04       Impact factor: 2.486

10.  Dentate nucleus iron deposition is a potential biomarker for tremor-dominant Parkinson's disease.

Authors:  Naying He; Pei Huang; Huawei Ling; Jason Langley; Chunlei Liu; Bei Ding; Juan Huang; Hongmin Xu; Yong Zhang; Zhongping Zhang; Xiaoping Hu; Shengdi Chen; Fuhua Yan
Journal:  NMR Biomed       Date:  2016-05-18       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.